Piper Sandler Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $2.5

Moomoo NewsApr 30 02:32 ET · Ratings

12 Health Care Stocks Moving In Monday's After-Market Session

BenzingaApr 28 17:05 ET

Express News | CytomX Therapeutics Presents Preclinical Data for Mrna Encoded Masked Il-12 Molecule in Collaboration With Moderna at AACR Annual Meeting

ReutersApr 28 16:00 ET

CytomX Therapeutics Presents Preclinical Data for MRNA Encoded Masked IL-12 Molecule in Collaboration With Moderna at AACR Annual Meeting

GlobeNewswireApr 28 16:00 ET

Piper Sandler Initiates CytomX(CTMX.US) With Hold Rating, Announces Target Price $2.5

Moomoo NewsApr 15 02:40 ET · Ratings

Piper Sandler Maintains Overweight on CytomX Therapeutics, Lowers Price Target to $2.5

BenzingaApr 14 10:49 ET · Ratings